PARP Inhibitors in Patients With Newly Diagnosed Advanced Ovarian Cancer: A Meta-Analysis of Randomized Clinical Trials

Background: The efficacy of poly(adenosine diphosphate–ribose) polymerase inhibitors (PARPi) as a maintenance therapy in patients with newly diagnosed advanced ovarian cancer remains unclear. We conducted a meta-analysis to assess the benefits and safety of PARPi maintenance therapy in patients with...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Front Oncol
Главные авторы: Wang, Yizi, Ren, Fang, Song, Zixuan, Wang, Xiaoying, Zhang, Chiyuan, Ouyang, Ling
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2020
Предметы:
Oncology
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7417336/
https://ncbi.nlm.nih.gov/pubmed/32850351
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01204
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы